ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Endoscopic Thoracic Sympathectomy for Primary Focal Hyperhidrosis: Impact on Psycho-Social Symptomatology and Psychotropic Medication Use

Tuesday, November 20, 2018

Submitted by

Claire Vernon

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezy211

Author(s)

Dan C Li, Alicia Hulbert, Benjamin Waldbaum, Cecily Ober, Craig M Hooker, Peng Huang, Daniela Molena, Stephen C Yang, Tomoaki Ito, Carisa Perry-Parrish, Malcolm V Brock

Primary focal hyperhidrosis (PFH) may lead to psychosocial deficits. One of the minimally invasive treatment methods is endoscopic thoracic sympathectomy, an effective therapeutic option that the authors hypothesized might lead to decreased psychotropic medications usage. Li and colleagues looked at psychiatric symptomatology and medication usage in 106 patients with PFH, comparing this with 213 patients without PFH. Additionally, they evaluated medication usage, anxiety, and depression before and after surgical intervention in PFH patients, finding improvements following endoscopic thoracic sympathectomy.